Perspective

Evaluation of Selective Prostaglandin E2 (PGE2) Receptor Agonists as Therapeutic Agents for the Treatment of Asthma

Science's STKE  27 Sep 2005:
Vol. 2005, Issue 303, pp. pe47
DOI: 10.1126/stke.3032005pe47

Log in to view full text

Navigate This Article